Aurélie Philippe

Graft microvascular disease in solid organ transplantation

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

Long COVID: major findings, mechanisms and recommendations

Shared and distinct mechanisms of fibrosis

Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation

Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts

Systemic sclerosis

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure

Vascular Signaling in Allogenic Solid Organ Transplantation – The Role of Endothelial Cells

Antibody-mediated graft injury

Endothelial Injury in Renal Antibody-Mediated Allograft Rejection

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis

Desensitization for solid organ and hematopoietic stem cell transplantation

Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis

Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature

Oxygen Sensing and Homeostasis

Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss

Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity

Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients

Role of non-HLA antibodies in organ transplantation

The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation

Non-HLA antibodies in solid organ transplantation

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome